ImageVerifierCode 换一换
格式:PPTX , 页数:41 ,大小:2.71MB ,
资源ID:11894765      下载积分:12 金币
快捷注册下载
登录下载
邮箱/手机:
温馨提示:
快捷下载时,用户名和密码都是您填写的邮箱或者手机号,方便查询和重复下载(系统自动生成)。 如填写123,账号就是123,密码也是123。
特别说明:
请自助下载,系统不会自动发送文件的哦; 如果您已付费,想二次下载,请登录后访问:我的下载记录
支付方式: 支付宝    微信支付   
验证码:   换一换

开通VIP
 

温馨提示:由于个人手机设置不同,如果发现不能下载,请复制以下地址【https://www.zixin.com.cn/docdown/11894765.html】到电脑端继续下载(重复下载【60天内】不扣币)。

已注册用户请登录:
账号:
密码:
验证码:   换一换
  忘记密码?
三方登录: 微信登录   QQ登录  

开通VIP折扣优惠下载文档

            查看会员权益                  [ 下载后找不到文档?]

填表反馈(24小时):  下载求助     关注领币    退款申请

开具发票请登录PC端进行申请

   平台协调中心        【在线客服】        免费申请共赢上传

权利声明

1、咨信平台为文档C2C交易模式,即用户上传的文档直接被用户下载,收益归上传人(含作者)所有;本站仅是提供信息存储空间和展示预览,仅对用户上传内容的表现方式做保护处理,对上载内容不做任何修改或编辑。所展示的作品文档包括内容和图片全部来源于网络用户和作者上传投稿,我们不确定上传用户享有完全著作权,根据《信息网络传播权保护条例》,如果侵犯了您的版权、权益或隐私,请联系我们,核实后会尽快下架及时删除,并可随时和客服了解处理情况,尊重保护知识产权我们共同努力。
2、文档的总页数、文档格式和文档大小以系统显示为准(内容中显示的页数不一定正确),网站客服只以系统显示的页数、文件格式、文档大小作为仲裁依据,个别因单元格分列造成显示页码不一将协商解决,平台无法对文档的真实性、完整性、权威性、准确性、专业性及其观点立场做任何保证或承诺,下载前须认真查看,确认无误后再购买,务必慎重购买;若有违法违纪将进行移交司法处理,若涉侵权平台将进行基本处罚并下架。
3、本站所有内容均由用户上传,付费前请自行鉴别,如您付费,意味着您已接受本站规则且自行承担风险,本站不进行额外附加服务,虚拟产品一经售出概不退款(未进行购买下载可退充值款),文档一经付费(服务费)、不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
4、如你看到网页展示的文档有www.zixin.com.cn水印,是因预览和防盗链等技术需要对页面进行转换压缩成图而已,我们并不对上传的文档进行任何编辑或修改,文档下载后都不会有水印标识(原文档上传前个别存留的除外),下载后原文更清晰;试题试卷类文档,如果标题没有明确说明有答案则都视为没有答案,请知晓;PPT和DOC文档可被视为“模板”,允许上传人保留章节、目录结构的情况下删减部份的内容;PDF文档不管是原文档转换或图片扫描而得,本站不作要求视为允许,下载前可先查看【教您几个在下载文档中可以更好的避免被坑】。
5、本文档所展示的图片、画像、字体、音乐的版权可能需版权方额外授权,请谨慎使用;网站提供的党政主题相关内容(国旗、国徽、党徽--等)目的在于配合国家政策宣传,仅限个人学习分享使用,禁止用于任何广告和商用目的。
6、文档遇到问题,请及时联系平台进行协调解决,联系【微信客服】、【QQ客服】,若有其他问题请点击或扫码反馈【服务填表】;文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“【版权申诉】”,意见反馈和侵权处理邮箱:1219186828@qq.com;也可以拔打客服电话:0574-28810668;投诉电话:18658249818。

注意事项

本文(中国糖尿病领域新挑战英文.pptx)为本站上传会员【精***】主动上传,咨信网仅是提供信息存储空间和展示预览,仅对用户上传内容的表现方式做保护处理,对上载内容不做任何修改或编辑。 若此文所含内容侵犯了您的版权或隐私,请立即通知咨信网(发送邮件至1219186828@qq.com、拔打电话4009-655-100或【 微信客服】、【 QQ客服】),核实后会尽快下架及时删除,并可随时和客服了解处理情况,尊重保护知识产权我们共同努力。
温馨提示:如果因为网速或其他原因下载失败请重新下载,重复下载【60天内】不扣币。 服务填表

中国糖尿病领域新挑战英文.pptx

1、Click to edit Master title style,Click to edit Master text styles,Second level,Third level,1,The Rising Challenge of Diabetes in China,Chang Yu Pan,Department of Endocrinology,Chinese PLA General Hospital,Chinese PLA,Endocrinology and Metabolism,C,entre and Key Laboratory,Apr.11-2008,2,Medical and

2、 Health Annual,Encyclopaedia Britannica,1999,3,3,Death from Diabetes 2.9,0,Million,(5.2%of total mortality,),Worldwide,:,1 of,20,death is from diabetes,(,About,8,700,death/day or,6,death/min,),About 1 of,4,death,is DM in Asia-Pacific Region,Death from AIDS:3.0,Million,What AIDS was in the last 20 ye

3、ars of the 20th century,diabetes is going to be in the first 20 years of this century,Roglic et al,2005,The Rising Challenge of Diabetes,4,Lifestyle changes,Urbanization and Longevity in China,National Nutrition and Health Survey,(1982 2002),Carbohydrate+10%,Meat,+57%,eggs,+69%,Total Carloria:2254ca

4、l./person/day,5,Prevalence of overweight/obesity in China(20-70 years),Overweight/obesity(BMI,25 kg/m,2,)(WHO criteria),Data from National Nutrition Survey(1992),the Working Group on Obesity in China(2002),Age-standardized Prevalence(%),6,Prevalence of overweight/obesity in Chinese children&adolesce

5、nts(2002),Data from 2002 National Nutrition and Health Survey,WGOC criteria,%,7,Prevalence of overweight/obesity in Chinese children&adolescents(1985-2000),Ji C et al,Chinese Journal of Epidemiology 2004,Prevalence(%),Boys,Girls,Ages,7-12 years,13-18 years,7-12 years,13-18 years,Year1985 Beijing,5.8

6、4.8,4.3,5.1,Shanghai,5.4,2.7,2.2,2.8,Coastal cities,1.9,1.5,1.3,0.6,Inland cities,0.6,0.7,2.2,1.8,Year1995 Beijing,17.5,18.1,12.0,11.6,Shanghai,20.5,15.7,11.8,8.0,Coastal cities,7.9,5.2,5.4,6.8,Inland cities,4.0,4.5,2.9,3.9,Year2000 Beijing,29.0,25.0,17.3,14.6,Shanghai,28.9,17.2,15.3,9.6,Coastal ci

7、ties,20.9,17.2,11.7,9.6,Inland cities,11.8,8.8,6.2,6.5,8,9,Global prevalence of diabetes,*,In 2007,the five countries with the largest numbers of people with diabetes are:,India,China,United States,Russia,Germany,By 2025,the largest increases in diabetes prevalence will occur in low-and middle-incom

8、e countries,Each year an additional 7 million people worldwide develop diabetes,*Diabetes Atlas,3rd edition,International Diabetes Federation,2006,10,Peoples Republic of China,Prediabetes,2003,33,million(4%),2025,54,million(5%),Diabetes,2003,23,million(3%),2025,46,million(4%),Sicree,Shaw,Zimmet.Diab

9、etes Atlas.IDF.www.idf.org.2006,The prevalence of DM is increasing rapidly,11,Growing prevalence of diabetes and prediabetes in China,National Diabetes Research Group.Chin J Int Med 20:678,1981,Pan XR,et al.Diabetes 20:1664,1997;Gu D,et al.Diabetologia 46:1190,2003,*Screening with FPG only,12,Preval

10、ence of IGT in all age groups was higher than that of Diabetes,Prevalence of IGT and Diabetes in 11 provinces,China,Prevalence,(,%,),0,2,4,6,8,10,12,20-30,30-40,40-50,50-60,60,Diabetes,IGT,Chin J Epidemiol.1998;19(5):282-285.,13,Shanghai Diabetes Institute,Isolated,fasting DM:0.6%,Isolated post-chal

11、lenge diabetes:2.4%,Combined DM:1.9%,Total prevalence of newly diagnosed DM:4.9%,Total prevalence of prediabetes:11.7%,Isolated IGT 8.8%,Isolated IFG 1.7%,IFG+IGT 1.2%,75%,15%,10%,Jia WP et al.Dibetologia 2007,Isolated post-challenge DM and IGT Common in China,14,Newly diagnosed diabetes(OGTT),33%,3

12、23%,24%,17%,36%,37%,27%,OGTT cohort(n=2,263),Whole population(n=3,513),2/3 of patients have hyperglycaemia,3/4 of patients have hyperglycaemia,Previously known diabetes,Newly diagnosed diabetes(FPG test),NGT,Prediabetes,Hu DY,Pan CY,Yu DM.,Eur Heart J 2006;27:25739.,China Heart Survey dysglycemia

13、is common in patients with CAD,15,WP Jia,et al.Diabetologia,2006(in press),Epidemiological characteristics DM and IGT in a Chinese adult population:the Shanghai Diabetes Studies(SHDS),Prevalence(%),Incidence(%),three-year cumulative incidence rates,incidence rates per year,1999-2001,n=5628,2002-2004

14、n=2709,16,Chinese individuals with IGT progress to type 2 diabetes faster than American individuals with IGT,2hPG levels of IGT controls in Da-Qing Study and DPP were similar(mean value 160mg/dL),17.2,11.1,13.3,0,2,4,6,8,10,12,14,16,18,20,Chinese BMI 22.4kg/m,2,ChineseBMI 27.5kg/m,2,AmericanBMI 34.

15、2kg/m,2,Incidence/100pys,Chinese IGT population is at high risk of DM,Pan XR,et al.Diabetes Care 1997;20:53744.,Knowler WC,et al.NEJM 2002;346:393,403.,17,Da Qing IGT intervention Study,577 IGT,519 Control,4%IGT,0.4%NGT,The appearance of ECG consistent with CHD,IGT and the risk of CVD,Diabetes Care

16、1993:16.150-156,18,IGT and Atherosclerosis,-Study from PLA General Hospital in China,*,*,*,IGT,NGT,DM,IGT,IGT,NGT,NGT,DM,DM,N:97(NGT),51(IGT),73(DM),Adjusted by age and sex,*P0.05,P0.005,v.s.,NGT,Jing WS,Pan CY,Lu JM,et al.Chin J Endocrinol 20(2):136-139,19,The cumulative rate of CVD,Coxs Proportion

17、al Harzard Model,Xu Xj,Pan CY Tian H.et al,Chin J Gerontol.2001,.,0.97,0.98,0.99,1.00,1,2,3,4,Year,NGT,IGT,DM,The CVD Risk of IGT and Diabetes-,Study from PLA General Hospital in China,Cumulative rate,0,20,CODIC2Control of Type 2 Diabetes in China,Biao X,Pan CY,Ji LN,et al.CODIC2,2007,in press,N=153

18、0,N=2054,N=524,21,Surveillance of Type 2 Diabetes in China,Grade of Hospitals,No.of,Hospitals,Patient,Numbers,1998,3,27,2430,2001,2&3,49,2248,2003,3,30,2729,2006,1,2&3,60,2779,2001 hospitals distribution:Grade 3:32(65%),Grade 2:17(35%),2006 hospitals distribution:Grade 3:43(72%),Grade 2:16(27%),Grad

19、e 1:1(2%),Patient Population,22,BMI,Anti-obesity Treatment:,2001,2003,2006,1.5%,1.0%,1.0%,BMI was analysed for patients 18 years only,24.6,24.3,24.0,23.7,10,15,20,25,30,1998,2001,2003,2006,BMI(kg/m,2,),Pan CY.Intern Journ Endocr.&Mtab.,2005,25(3):174-178.,23,WAIST,90.8,87.2,80,85,90,95,100,105,Male,

20、Female,Waist(cm),Mean Waist in 2006,%Waist 90cm(Male),80cm(Female),2003,2006,Waist was analysed for patients 18 years only,51.1,75.9,54.9,78.3,40,45,50,55,60,65,70,75,80,85,Male,Female,Proportion of Patients(%),Pan CY.Intern Journ Endocr.&Mtab.,2005,25(3):174-178,24,MEAN HbA,1c,LEVELS,%HbA1c 6.5%,8%

21、26%,11%,23%,%HbA1c 7%,18%,41%,26%,41%,Local HbA,1c,(past 12 month):57%(1998),31%(2001),55%(2003),54%(2006),8.8,7.7,7.5,7.6,0,1,2,3,4,5,6,7,8,9,10,11,12,Mean HbA,1c,(%),6.5%,Nine years change in diabetes management,DIABCARE Study Result(1998-2006),2003,2001,1998,2006,Pan CY.Intern Journ Endocr.&Mtab

22、2005,25(3):174-178,25,LIPID PROFILES,Target TC:1.1 mmol/L TG:1.5 mmol/L,43%,41%,41%,41%,32%,31%,28%,34%,52%,60%,60%,61%,5.0,5.1,5.1,4.9,3.5,4.5,5.5,1998,2001,2003,2006,mmol/L,1.3,1.4,1.3,1.4,1.0,1.1,1.2,1.3,1.4,1.5,1998,2001,2003,2006,1.9,2.0,1.9,2.1,1.0,1.2,1.4,1.6,1.8,2.0,2.2,2.4,2.6,1998,2001,2

23、003,2006,TC,HDL-c,TG,Pan CY.Intern Journ Endocr.&Mtab.,2005,25(3):174-178,26,Type of Treatment for Dyslipidaemia,Treated for Dyslipidaemia%,Statin,%,2001,25,12,2003,25,13,2006,27,17,Pan CY.Intern Journ Endocr.&Mtab.,2005,25(3):174-178,27,HYPERTENSION,+,+sbp/dbp,130/80(recommendation on optimal contr

24、ol of,ADA 2004&AP guidelines 2002),Treatment for Hypertension,2001:44%,2003:48%,2006:53%,1998 2001 2003 2006,Smoking:,14%,18%,17%,21%,Drinking:,14%,11%,11%,16%,Patient is,currently,a smoker or,consumes alcohol(Regular consumption is defined as,more than 3 times per week),76.1,77.2,0,10,20,30,40,50,6

25、0,70,80,2003,2006,Proportion of Patients(%),response rate 98%99%,Pan CY.Intern Journ Endocr.&Mtab.,2005,25(3):174-178,28,METABOLIC SYNDROME,Criteria,MS%,CDS,61.4,IDF,59.9,CDS-Chinese Diabetes Society IDF-International Diabetes Federation,29,About 55%DM outpatients have complications,Biao X,Pan CY,Ji

26、 LN,et al.CODIC2,2007,in press,Top three complications,Complication of,Type 2 Diabetes in China,30,Global cost of diabetes*,Economic and societal costs mainly arise from complications of diabetes,Economic consequences result largely from:,Cost of care,Loss of productivity due to disability and prema

27、ture death,In 2007,global health expenditures to treat and prevent diabetes total at least,US$232 billion,*Diabetes Atlas,3rd edition,International Diabetes Federation,2006,31,Total Direct Medical Cost of treating Type 2 DM in urban China,Billion RMB,4.38%,Chen Xingbao.Chinese health economics,2003*

28、Tang Ling.China Diabetic Journal.2003*,32,Direct Medical Cost for patients with Diabetes in China,Billion RMB,18,.9%,81.1%,0.00%,50.00%,100.00%,Direct Medical Cost,Direct Medical Cost for patients,with complication),(,Direct Medical Cost for patients,without complications),Chen Xingbao.Chinese heal

29、th economics,2003*,Tang Ling.China Diabetic Journal.2003*,33,Effect of complications on costs,Increase in costs vs.no complications,218%,313%,935%,Chen Xingbao.Chinese health economics,2003*Tang Ling.China Diabetic Journal.2003*,Total Direct Medical Cost of treating Type 2 DM in urban China,RMB,34,C

30、HD deaths than expected from,baseline,mortality rates,Data from England and Wales between 1981 and 2000 in men and women aged 3584 years,There were 68,230 fewer CHD deaths than expected from baseline mortality rates in 1981,-100,000,-80,000,-60,000,-40,000,-20,000,0,20,000,Deaths prevented or postpo

31、ned,in 2000,Factors,CHD deaths,include,smoking,cholesterol,and BP and,changes in treatments,Factors,CHD deaths,include,diabetes,and,obesity,Unal B,et al.Circulation,2004;109:11011107.,延迟或预防死亡,68,230,(,2,0003,000,),35,D,iabetes mortality continues,its steady escalation,Freid VM,et al.,National Center

32、 for Health Statistics,2003,.,Year,Age,adjusted death raterelative to 1980,cerebrovascular disease,40,60,80,100,120,140,1980,1990,2000,H,eart disease,Cancer,Diabetes,36,Cause of death in China,Data from National Disease Surveillance System of China(1991-2000),Top 3 fatal diseases in 2000,1,412,999,2

33、488,266,1,530,423,Cause of death in China,37,Motality of Diabetes in Urban Chinese,Sources:Ministry of Health of China:Annual Statistical Reports of Death,injuries and Cause of Death 2001,38,WPDD 2002.www.wpdd.org/downloads/Diabetes_Book.pdf.,Early,D,iagnosis of,P,rediabetes is essential,Western Pa

34、cific Diabetes Declaration(WPDD),G,uidelines:,“,The risk of,C,omplications is,R,elated to the,D,uration of,D,iabetes,as well as the,D,egree of,H,yperglycaemia.However,due to,D,elayed,D,iagnosis,t,hese,C,omplications may,A,lready be,P,resent at,D,iagnosis.”,Early diagnosis and management of prediabet

35、escan reduce the risk of both type 2 diabetes and cardiovascular disease,39,Summary,The prevalence of DM and IGT is increasing rapidly as a result of lifestyle changes,urbanization and longevity.,China is currently the second on the list of the top ten countries with the highest DM burden,Estimated

36、that as the population of China reaches 1.3 billion in the early 21st century,700,000 new cases of type 2 diabetes occur every year among 24-74 year-old HbA1c and CVD risk factors control with current treatment is poor;,In China,81%Of total direct medical cost for patients with complications,Even,IGT,are associated with increased cardiovascular risk and mortality driven largely by postprandial hyperglycaemia,40,Conclusion,Prediabetes(IGT),might,be,Optimal Time for Intervention of,Diabetes and CVD Prevention,Early,D,iagnosis of,P,rediabetes,and DM,is essential,41,Thank you!,

移动网页_全站_页脚广告1

关于我们      便捷服务       自信AI       AI导航        抽奖活动

©2010-2026 宁波自信网络信息技术有限公司  版权所有

客服电话:0574-28810668  投诉电话:18658249818

gongan.png浙公网安备33021202000488号   

icp.png浙ICP备2021020529号-1  |  浙B2-20240490  

关注我们 :微信公众号    抖音    微博    LOFTER 

客服